Boundless Bio, Shares Owned By Institutions vs. Cash And Equivalents
| BOLD Stock | USD 3.10 0.25 8.77% |
For Boundless Bio, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Boundless Bio, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Boundless Bio, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Boundless Bio,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Boundless Bio, Common over time as well as its relative position and ranking within its peers.
Boundless |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Return On Assets (0.24) | Return On Equity (0.36) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Boundless Bio, Common Cash And Equivalents vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Boundless Bio,'s current stock value. Our valuation model uses many indicators to compare Boundless Bio, value to that of its competitors to determine the firm's financial worth. Boundless Bio, Common is number one stock in shares owned by institutions category among its peers. It also is number one stock in cash and equivalents category among its peers creating about 4,471,558 of Cash And Equivalents per Shares Owned By Institutions. Comparative valuation analysis is a catch-all technique that is used if you cannot value Boundless Bio, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Boundless Cash And Equivalents vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Boundless Bio, |
| = | 78.60 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Boundless Bio, |
| = | 351.46 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Boundless Cash And Equivalents Comparison
Boundless Bio, is currently under evaluation in cash and equivalents category among its peers.
Boundless Bio, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Boundless Bio,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Boundless Bio, will eventually generate negative long term returns. The profitability progress is the general direction of Boundless Bio,'s change in net profit over the period of time. It can combine multiple indicators of Boundless Bio,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 40 K | 42 K | |
| Operating Income | -54.8 M | -57.5 M | |
| Income Before Tax | -49.4 M | -51.9 M | |
| Total Other Income Expense Net | 5.4 M | 5.6 M | |
| Net Loss | -49.4 M | -51.9 M | |
| Income Tax Expense | -5.3 M | -5 M | |
| Net Interest Income | 5.3 M | 5.5 M | |
| Interest Income | 5.3 M | 5.5 M | |
| Net Loss | -49.4 M | -51.9 M | |
| Net Loss | (2.22) | (2.33) | |
| Income Quality | 0.95 | 0.71 | |
| Net Income Per E B T | 0.88 | 0.78 |
Boundless Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Boundless Bio,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Boundless Bio, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Boundless Bio,'s important profitability drivers and their relationship over time.
Use Boundless Bio, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boundless Bio, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will appreciate offsetting losses from the drop in the long position's value.Boundless Bio, Pair Trading
Boundless Bio, Common Pair Trading Analysis
The ability to find closely correlated positions to Boundless Bio, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boundless Bio, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boundless Bio, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boundless Bio, Common to buy it.
The correlation of Boundless Bio, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boundless Bio, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boundless Bio, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boundless Bio, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Boundless Bio, position
In addition to having Boundless Bio, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electrical Equipment Thematic Idea Now
Electrical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
To fully project Boundless Bio,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Boundless Bio, Common at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Boundless Bio,'s income statement, its balance sheet, and the statement of cash flows.